Shirley Ryan AbilityLab

Open enrollment with an early-phase pipeline tilt

According to ClinicalTrials.gov-derived indexes, Shirley Ryan AbilityLab sits in the top decile of US sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count).

138 total trials 36 currently recruiting 69 completed early-phase tilt top decile by trial count

Shirley Ryan AbilityLab: 138 sponsored US clinical trials, 36 recruiting.

Shirley Ryan AbilityLab sponsors 138 registered US clinical trials on ClinicalTrials.gov, 36 of them currently recruiting, and 69 completed. 5 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 24 trials.

Top-decile sponsor footprint

Shirley Ryan AbilityLab ranks in the top decile of sponsors by registered trial count (#204 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

C 79/100

69 of 72 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (95.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

138 total, page 3 of 3

COMPLETED NA

The Effect of Powered-Knee Exoskeleton Assist on Stair Climbing in Acute CVA

NCT03264235
COMPLETED NA

In Home VR Therapy

NCT03062345
COMPLETED Phase 3

Ventilatory Muscle Training in Stroke

NCT02828943
COMPLETED NA

LifeWalker Upright Walker vs. Conventional Rollator Walker and Predicate Device

NCT02968277
COMPLETED NA

Intermittent Hypoxia and Upper Extremity EMG Recordings in Individuals With Spinal Cord Injury

NCT05513911
COMPLETED NA

Altering Activation Patterns Post-stroke

NCT02418949
COMPLETED NA

The Intensive Comprehensive Aphasia Program (ICAP)

NCT03514186
COMPLETED NA

Very Intensive Variable Repetitive AmbulatioN Training

NCT02507466
COMPLETED NA

Adaptive Recalibration of Prosthetic Leg Neural Control System

NCT02355912
COMPLETED NA

Thigh Reduction Surgery of Above Knee Amputee Residual Limbs to Improve Prosthesis Fit and Patient Outcomes

NCT02346019
COMPLETED

Diet and Activity in Cerebral Palsy

NCT02175108
TERMINATED NA

Cycling in Parkinson's Disease

NCT02175082
COMPLETED NA

Pushing Behaviors in Individuals Post-stroke

NCT02190734
COMPLETED NA

Sympathetic-Somatomotor Coupling in Human Spinal Cord Injury

NCT02115685
COMPLETED NA

Identify Training Strategies for Progressing Exoskeleton Users Towards Everyday Functional Ambulation

NCT02104622
COMPLETED NA

Development of Walk Assist Device to Improve Community Ambulation

NCT01994395
COMPLETED NA

Comparison of Pattern Recognition Control and Direct Control in TMR

NCT03097978
COMPLETED NA

Deficit Fields for Stroke Recovery

NCT02570256
COMPLETED NA

Enhancing Written Communication in Persons With Aphasia

NCT01790880
TERMINATED Phase 4

Efficacy of Gralise® for Chronic Pelvic Pain

NCT01678911
COMPLETED Phase 4

Pathophysiology of Post Amputation Pain

NCT01632709
COMPLETED

Survey on Return to Work After Stroke

NCT01699035
COMPLETED NA

Traditional Balance vs Vibrotactile Feedback Training for Vestibular Rehabilitation

NCT01672658
COMPLETED Phase 4

True Functional Restoration and Analgesia in Non-Radicular Low Back Pain

NCT01455519
COMPLETED NA

Functional Outcomes in Dysvascular Transfemoral Amputees

NCT01537211
COMPLETED NA

Aphasia Rehabilitation: Modulating Cues, Feedback & Practice

NCT01597037
COMPLETED NA

Simulated Home Therapy Program for the Hand After Stroke

NCT02072369
COMPLETED NA

Balance Training in Parkinson's Disease Using the Wii Balance Board

NCT01228851
COMPLETED Phase 1

Transcranial Direct Current Stimulation and Aphasia Language Therapy

NCT01486654
COMPLETED NA

Walk Assist Device to Improve Community Ambulation

NCT03222505
COMPLETED Phase 1

Contrastim Stroke Trial

NCT01049802
COMPLETED NA

Very Intensive Early Walking in Stroke

NCT01789853
COMPLETED NA

Lubiprostone (Amitiza®) Vs. Standard Care in Opioid-induced Constipation After Surgery in Inpatient Rehabilitation

NCT00662363
COMPLETED NA

Evaluating Error Augmentation for Neurorehabilitation

NCT01574495
COMPLETED NA

Development of Low Cost Devices to Increase Access to Treadmill Training

NCT02560506
COMPLETED Phase 2

Augmenting Language Therapy for Aphasia: Levodopa

NCT01429077
COMPLETED Phase 1

Enhanced Motor Recovery Using Serotonergic Agents in Stroke

NCT01751854
COMPLETED NA

Randomized DB Controlled Trial of Botulinum Toxin A in Hemiplegic Shoulder Pain and Spasticity

NCT00661089
← Previous Page 3 of 3

Phase Distribution

PhaseTrial count
Phase 1 8
Phase 2 3
Phase 3 1
Phase 4 4

Therapeutic Areas

Stroke 24
Spinal Cord Injuries 8
Amputation 7
Multiple Sclerosis 7
Spinal Cord Injury 5
Multiple Sclerosis, Secondary Progressive 4
Multiple Sclerosis (Relapsing Remitting) 4
Parkinson Disease 3
Amputation; Traumatic, Limb 2
Post-polio Syndrome 2

What is open in the Shirley Ryan AbilityLab pipeline

36 recruiting of 138 indexed (26% open); 69 completed (50%).

Phase mix: 5 late (III/IV) vs 11 early (I/II) (early-phase heavy).

Top condition: Stroke (24 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Shirley Ryan AbilityLab: open-pipeline peers nationwide

Peers matched on 138 registered trials and 26% open enrollment, not the therapeutic-area sidebar.

Shirley Ryan AbilityLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 0100200300400500 0%10%20%30% Total trials Recruiting share Shirley Ryan AbilityLabSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityBarbara Ann Karmanos Cancer InstituteCenters for Disease Control and PreventionMclean HospitalUniversity Health Network, TorontoSyracuse UniversityRutgers, The State University of New JerseyHackensack Meridian Health
Shirley Ryan AbilityLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Shirley Ryan AbilityLab sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 138 trials (± recruiting share)

Sponsors near 26% open enrollment (± trial volume)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Shirley Ryan AbilityLab page

138 registered trials is a research-attention snapshot, not an endorsement of Shirley Ryan AbilityLab or any single study.

  • 36 of Shirley Ryan AbilityLab's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Stroke is the condition Shirley Ryan AbilityLab studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Shirley Ryan AbilityLab pipeline card: 138 registered trials from official public datasets.Report a data error.